Accès ouvert
2025
article
OpenAlex
Dillon S. McDevitt, Joshua D. Vardigan, Xiaoping Zhou, Thomas W. Rosahl et autres
• MSD199 is a potent and selective Nav1.8 inhibitor. • Humanized rats can overcome species potency shifts in developing NaV1.8 inhibitors. • MSD199 demonstrates preclinical efficacy in SNL and CFA. Voltage-gated sodium channel isoform 1.8 (Na V 1.8) has emerged as a …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Joshua D. Vardigan, Parul S. Pall, Dillon S. McDevitt, Chien-Jung Huang et autres
ABSTRACT: Voltage-gated sodium (Na v ) channels present untapped therapeutic value for better and safer pain medications. The Na v 1.8 channel isoform is of particular interest because of its location on peripheral pain fibers and demonstrated role in rodent preclinical pain …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Jeanine Ballard, Parul S. Pall, Joshua D. Vardigan, Fuqiang Zhao et autres
MK-2075 is a small-molecule selective inhibitor of the NaV1.7 channel investigated for the treatment of postoperative pain. A translational strategy was developed for MK-2075 to quantitatively interrelate drug exposure, target modulation, and the desired pharmacological response in preclinical animal models for the …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Gregory L. Adams, Parul S. Pall, Steven M. Grauer, Xiaoping Zhou et autres
Inhibitor cystine knot peptides, derived from venom, have evolved to block ion channel function but are often toxic when dosed at pharmacologically relevant levels in vivo . The article describes the design of analogues of ProTx-II that safely display systemic in vivo …
us, it
(code pays fourni par la source)
2021
article
OpenAlex
Richard L. Kraus, Fuqiang Zhao, Parul S. Pall, Dan Zhou et autres
1.7 target modulation in rhesus macaques and determine the plasma concentration required to produce a predetermined level of inhibition. The calculated plasma concentration for preclinical efficacy could be used to guide human efficacious exposure estimates. Given the translatable nature of the assays …
us, gb
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Jeanine Ballard, Parul S. Pall, Joshua D. Vardigan, Fuqiang Zhao et autres
PURPOSE: This work describes a staged approach to the application of pharmacokinetic-pharmacodynamic (PK-PD) modeling in the voltage-gated sodium ion channel (NaV1.7) inhibitor drug discovery effort to address strategic questions regarding in vitro to in vivo translation of target modulation. METHODS: PK-PD analysis …
us
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Joshua D. Vardigan, Andrea K. Houghton, Henry S. Lange, Emily D. Adarayan et autres
INTRODUCTION: The development of novel analgesics to treat acute or chronic pain has been a challenge due to a lack of translatable measurements. Preclinical end points with improved translatability are necessary to more accurately inform clinical testing paradigms, which may help guide …
us
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Christine L. Weisshaar, Jeffrey V. Kras, Parul S. Pall, Sonia Kartha et autres
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Jeffrey V. Kras, Christine L. Weisshaar, Parul S. Pall, Beth A. Winkelstein
us
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Parul S. Pall, Olivia Hurwitz, Brett King, Robert H. LaMotte
us
(code pays fourni par la source)